» Authors » Wojciech Krajewski

Wojciech Krajewski

Explore the profile of Wojciech Krajewski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 214
Citations 1319
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, et al.
BJU Int . 2025 Feb; PMID: 39967051
Objective: To assess the oncological outcomes of patients with high-risk (HR) and very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette-Guérin (BCG) instillations...
2.
Krajewski W, Guzinski M, Laszkiewicz J, Tomczak W, Chelmonski A, Grunwald K, et al.
Contemp Oncol (Pozn) . 2025 Feb; 28(4):335-340. PMID: 39935758
Introduction: Partial nephrectomy (PN) is the primary treatment for T1 renal cell carcinoma (RCC). Also, percutaneous cryoablation is gaining attention as a curative option in appropriately selected patients. However, even...
3.
Bardowska K, Krajewski W, Kolodziej A, Koscielska-Kasprzak K, Bartoszek D, Zabinska M, et al.
World J Urol . 2025 Feb; 43(1):114. PMID: 39928162
Purpose: To prospectively evaluate prognostic capabilities of non-muscle invasive bladder cancer (NMIBC) biomarkers for predicting disease recurrence or progression after radical TURB (transurethral resection of bladder tumor). Methods: Evaluated biomarkers...
4.
Gallioli A, Uleri A, Verri P, Tedde A, Mertens L, Moschini M, et al.
Eur Urol Focus . 2025 Feb; PMID: 39894734
Background And Objective: Data about the mid- and long-term oncologic outcomes of endoscopic kidney-sparing surgery (eKSS) for upper tract urothelial carcinoma (UTUC) are scarce. Therefore, we aimed to summarize the...
5.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Laukhtina E, et al.
Cancer Immunol Immunother . 2025 Feb; 74(3):76. PMID: 39891702
Recent phase 3 randomized controlled trials (RCTs) demonstrate the promising impact of immune checkpoint inhibitor (ICI)-based combination therapies on locally advanced or metastatic urothelial carcinoma (UC). However, comparative data on...
6.
Tresh A, Del Giudice F, Li S, Basran S, De Berardinis E, Carino D, et al.
BJUI Compass . 2025 Jan; 6(1):e481. PMID: 39877570
Objectives: To assess the impact of a positive history of venous thromboembolism (VTE) on perioperative outcomes, including length of in-hospital stay, readmission rates, 90-day postoperative complications, and healthcare costs in...
7.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, et al.
BJU Int . 2025 Jan; PMID: 39797535
Objective: To evaluate the oncological efficacy and safety of sequential intravesical gemcitabine/docetaxel (Gem/Doce) therapy in a European cohort of patients with high-risk and very-high-risk non-muscle-invasive bladder cancer (NMIBC) after previous...
8.
Santarelli V, Carino D, Corvino R, Salciccia S, De Berardinis E, Krajewski W, et al.
Cancers (Basel) . 2025 Jan; 17(1. PMID: 39796651
: Robot-assisted radical prostatectomy (RARP) for the treatment of prostate cancer (PCa) has been standardized over the last 20 years. At our institution, only n = 3 rob arms are...
9.
Guzinski M, Krajewski W, Tomczak W, Nowak L, Laszkiewicz J, Chorbinska J, et al.
Pol J Radiol . 2025 Jan; 89():e526-e530. PMID: 39777325
Purpose: The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of...
10.
Laszkiewicz J, De Berardinis E, Krajewski W, Nowak L, Szydelko T, Carino D, et al.
Asian J Androl . 2024 Dec; PMID: 39726203
Implantation of inflatable penile prosthesis should be considered as a definitive treatment of erectile dysfunction. However, the sole procedure might not allow for optimal dimensional and functional outcomes. The aim...